Shandong Luoxin Pharmacy Stock Co., Ltd

Shandong Luoxin Pharmaceutical Group Co., Ltd. is a joint-stock company jointly established by 11 sponsors including Shandong Luoxin Pharmaceutical Factory, Luoxin Pharmaceutical Group Co., Ltd., and Shenyang Pharmaceutical University. It strictly follows the modern enterprise system It is a pharmaceutical enterprise established according to national GMP requirements. The company has been rated as a "AAA①" honest enterprise by the Ministry of Commerce. The "Luoxin" trademark has been recognized as a "China Famous Trademark" by the Trademark Office of the State Administration for Industry and Commerce. It has been awarded "AAA Level Creditworthy Enterprise" and "AAA Credit Enterprise" by the country, province and city many times. "Contract-abiding and Credit-worthy Enterprise", "Civilized Unit", "Advanced Unit in the Pharmaceutical Industry" and other honorary titles. The company's shares were listed on the H-share market in Hong Kong in December 2005. Since 2006, the company has continuously entered the top 100 enterprises in China's pharmaceutical industry and the top ten most promising pharmaceutical companies in China. It is a national key high-tech enterprise. The company has been recognized successively For the "National Comprehensive New Drug Research and Development Technology University" Platform (Shandong) Industrialization Demonstration Enterprise", "Best Industrial Enterprise in China's Pharmaceutical R&D Product Line", "Top 100 Enterprises with Advanced Enterprise Education Units in China", "China Patent Shandong Star Enterprise", "China's Excellent Private Technology Enterprise", " "Shandong Province Innovative Pilot Enterprise" and has a national Fang Lianhe Engineering Laboratory, Nationally Recognized Enterprise Technology Center, "Taishan Scholar - Distinguished Expert in Pharmacy" position, Shandong Enterprise Academician Workstation, Shandong Province Lyophilized Powder Injection Pharmaceutical Engineering Technology Research Center, Shandong Province Lyophilized Powder Injection Pharmaceutical Engineering Laboratory , Shandong Province’s key implementation areas for freeze-dried powder injection drugs Laboratory. After review by the Ministry of Human Resources and Social Security and the National Postdoctoral Management Committee, the company was approved to establish a national postdoctoral research station to provide services for the company to cultivate, attract and use high-level professional and technical talents, enhance research and development capabilities, and promote the construction of an innovation system. A new vast space. The company adheres to the strategy of "revitalizing the enterprise through science and technology" and actively cooperates with major universities and scientific research institutions across the country. With Shenyang Pharmaceutical University and other higher scientific research institutes as scientific research backing, it has also established the "Shenyang Pharmaceutical University Luoxin Pharmaceutical Postdoctoral Mobile Workstation" ", "Shenyang Pharmaceutical University Luoxin Pharmaceutical Teaching and Training Base", "Shenyang Pharmaceutical University Luoxin Pharmaceutical Internship Base", "Shenyang Pharmaceutical University Luoxin Pharmaceutical Graduates Employment Base", "Union "Collaborative Laboratory", etc. 5 of the company's products have been included in the national "Major New Drug Creation" major science and technology projects, 2 products have been included in the "National Key New Product Plan", 4 products have been included in the "National Torch Plan", 78 Several projects have been included in the Shandong Provincial Torch Plan, Shandong Provincial Science and Technology Development Plan, and Shandong Provincial Technological Innovation Projects. Many products have won the "Science and Technology Progress Award", including 8 traditional Chinese medicine freeze-dried powder injections, such as Forskolin. Two products have obtained Chinese invention patent certificates and have been protected for 20 years. Currently, the company has three production and manufacturing bases, including powder injections, freeze-dried powder injections, solid preparations (including cephalosporins), sprays, aerosols, There are more than 50 production lines for pre-filling, large-volume injections, small-volume injections, chemical APIs, and cephalosporin APIs, and more than a dozen dosage forms and more than 300 product specifications have been launched. market, including 46 national-level new drugs. The company can annually produce 600 tons of APIs, 1 billion powder injections, 500 million freeze-dried powder injections, 500 million small-volume injections, and 400 million large-volume injections (bottles). ), 7 billion tablets, 2 billion capsules, 300 million bags of granules, 300 tons of pellets, 80 million bags of dry suspensions, 30 million aerosols, 100 million sprays, 1 pre-filled Billions of sticks. The company actively implements the strategy of using technology to create product brands, using famous brand products to increase corporate visibility, and using corporate visibility to drive product sales, which has laid a solid foundation for corporate development. In order to speed up the implementation of technological innovation, the company has increased its investment in science and technology. The company is accelerating the implementation of more than 30 scientific research projects and more than 20 clinical verification projects, including many first-class new drugs with independent intellectual property rights implemented in preclinical and clinical trials. Luoxin Pharmaceutical's market network is radiating across the country at a rapid pace. With the platform of Luoxin's stock being listed in Hong Kong, Luoxin is quickly entering the international market and keeping pace with the world in the two fields of products and marketing. In order to speed up the development of the enterprise, the company is currently fully implementing the strategy of promoting "three improvements" through "five breakthroughs". Five breakthroughs: 1. Breakthrough in production dosage forms (adding water injection and large infusion dosage forms to existing dosage forms); 2. Breakthrough in production and operation scale (expanding raw materials and Yuxin branch); 3. Breakthrough in technological innovation (Accelerate the early launch of a new class of new drugs with independent intellectual property rights currently under development); 4. The expansion of the group’s large-scale operations Breakthrough (on the basis of expanding the pharmaceutical logistics city, gradually implement the transformation of provincial offices across the country into pharmaceutical commercial branches, improve the drug distribution function and improve the company's distribution service system, and better leverage the advantages of industrial and commercial integration); 5. Breakthroughs in the capital market (creating a better financing platform and laying a continuous financing channel for corporate development). Promote three improvements: 1. Improvement of corporate brand (the company's goodwill, product brand, and staff quality will be greatly improved to create an international brand); 2. Improvement of corporate values ​​(Luo Xin's values ​​​​are " Repay employees, repay customers, repay shareholders, repay society, and strengthen the enterprise. ① Repay employees: provide employees with greater development space and returns. ② Repay customers: provide Customers create the greatest value space required. ③Return to shareholders: stock prices and earnings will see significant improvements and breakthroughs. ④Return to society: contribute more tax dollars to the country, actively participate in social relief, and provide employment opportunities for the society. Provide more and better high-tech drugs for the treatment and rehabilitation of patients. ⑤ Strong enterprise: Luo Xin will be better, bigger and stronger); 3. Improvement of scale efficiency. Strengthen and improve seven innovations (concept, system, technology, management, mechanism, market development, human resources development and innovation). Luoxin Pharmaceutical will always adhere to the guiding ideology of honesty, reform and innovation, continue to create the greatest value space for our customers, and insist on facing customers with high-quality products, preferential prices, and excellent services. We are willing to work hand in hand with colleagues in the medical field to create brilliance together.